BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 01-Nov-2020

(Continuation news of BXPHARMA): The Bonus Share is declared out of accumulated profit. The Bonus Share is not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post-dividend retained earnings become negative. (end)

BXPHARMA 01-Nov-2020

Dividend Declaration (Additional Information): The Company has further informed that declared Bonus Share along with the Cash Dividend considering its requirements of cash for the ongoing expansion projects and the investment needed in connection with Covid-19 Vaccine for which an exclusive distribution agreement has been signed with Serum Institute of India Pvt. Ltd (SII). (cont.)

BXPHARMA 29-Oct-2020

The Board of Directors has recommended 15% cash and 10% stock dividend for the year ended on June 30, 2020. Date of AGM: 19.12.2020, Time: 10:30 AM, Venue: Digital Platform. Record Date: 25.11.2020. The Company has also reported Consolidated EPS of Tk. 8.67, Consolidated NAV per share of Tk. 80.12 and Consolidated NOCFPS of Tk. 13.67 for the year ended on June 30, 2020 as against Tk. 7.48, Tk. 72.96 and Tk. 7.30 respectively for the same period of the previous year.

BXPHARMA 20-Jan-2020

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2019 to the respective shareholders' Bank Accounts through BEFTN system.

BXPHARMA 29-Oct-2019

The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2019. Date of AGM: 21.12.2019, Time: 10:30 AM, Venue: Beximco Industrial Park, Sarabo, Kashimpur, Gazipur. Record Date: 25.11.2019. (cont.)

BXPHARMA 21-Jan-2019

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2018 to the respective shareholders' Bank Accounts through BEFTN system.

BXPHARMA 28-Oct-2018

The Board of Directors has recommended 12.50% cash dividend for the year ended on June 30, 2018. The Board has also decided to hold an EGM to pass Special Resolutions to amend certain Clauses of Memorandum of Association and Articles of Association of the Company. Date of EGM & AGM: 22.12.2018, Time for EGM & AGM: 10:00 AM & 10:30 AM respectively, Venue: Beximco Industrial Park, Sarabo, Kashimpur, Gazipur. Record Date: 26.11.2018. (cont.)

BXPHARMA 18-Jan-2018

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2017 to the respective shareholders' Bank Accounts through BEFTN system.

BXPHARMA 26-Oct-2017

The Board of Directors has recommended 12.50% cash dividend for the year ended on June 30, 2017. Date of AGM: 23.12.2017, Time: 10:00 AM, Venue: Beximco Industrial Park, Sarabo, Kashimpur, Gazipur. Record Date: 15.11.2017. (cont.)

BXPHARMA 15-Dec-2016

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2016 to the respective shareholders' Bank Accounts through BEFTN system.

Previous Next page